<?xml version='1.0' encoding='utf-8'?>
<document id="28070719"><sentence text="Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice."><entity charOffset="0-9" id="DDI-PubMed.28070719.s1.e0" text="Sunitinib" /><entity charOffset="10-21" id="DDI-PubMed.28070719.s1.e1" text="paracetamol" /><pair ddi="false" e1="DDI-PubMed.28070719.s1.e0" e2="DDI-PubMed.28070719.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28070719.s1.e0" e2="DDI-PubMed.28070719.s1.e1" /></sentence><sentence text="The sex-divergent pharmacokinetics and interaction of tyrosine kinase inhibitor sunitinib with paracetamol was evaluated in male and female mice"><entity charOffset="54-62" id="DDI-PubMed.28070719.s2.e0" text="tyrosine" /><entity charOffset="80-89" id="DDI-PubMed.28070719.s2.e1" text="sunitinib" /><entity charOffset="95-106" id="DDI-PubMed.28070719.s2.e2" text="paracetamol" /><pair ddi="false" e1="DDI-PubMed.28070719.s2.e0" e2="DDI-PubMed.28070719.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28070719.s2.e0" e2="DDI-PubMed.28070719.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28070719.s2.e0" e2="DDI-PubMed.28070719.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28070719.s2.e1" e2="DDI-PubMed.28070719.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28070719.s2.e1" e2="DDI-PubMed.28070719.s2.e2" /></sentence><sentence text=" Mice (control groups) were administered 60 mg/kg PO sunitinib alone or with 200 mg/kg PO paracetamol (study groups)"><entity charOffset="90-101" id="DDI-PubMed.28070719.s3.e0" text="paracetamol" /></sentence><sentence text=" Sunitinib concentration in plasma, brain, kidney and liver were determined and non-compartmental pharmacokinetic analysis performed"><entity charOffset="1-10" id="DDI-PubMed.28070719.s4.e0" text="Sunitinib" /></sentence><sentence text=" Female control mice showed 36% higher plasma sunitinib AUC0→∞, 31% and 27% lower liver and kidney AUC0→∞ and 2" /><sentence text="2-fold higher AUC0→∞ in brain (all p &lt; 0" /><sentence text="001) and had lower liver- and kidney-to-plasma AUC0→∞ ratios (p &lt; 0" /><sentence text="001) than male control mice" /><sentence text=" Paracetamol decreased 29% plasma AUC0→∞ (p &lt; 0"><entity charOffset="1-12" id="DDI-PubMed.28070719.s9.e0" text="Paracetamol" /></sentence><sentence text="05) in male mice and remained unchanged in female mice" /><sentence text=" In male and female mice, it decreased liver (15%, 9%), kidney (15%, 20%) and brain (47%, 50%) AUC0→∞ (p &lt; 0" /><sentence text="001) respectively owing to 52% brain uptake efficiency reduction in female mice (p &lt; 0" /><sentence text="01)" /><sentence text=" Sunitinib displayed sex-divergent pharmacokinetics, tissue distribution and DDI with potential clinical translatability for the treatment of brain tumor and RCC patients"><entity charOffset="1-10" id="DDI-PubMed.28070719.s14.e0" text="Sunitinib" /></sentence><sentence text="" /></document>